FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308181635> ?p ?o ?g. }

• W4308181635 endingPage "039463202211330" @default.
• W4308181635 startingPage "039463202211330" @default.
• W4308181635 abstract "Objectives Niloticin is an active compound isolated from Cortex phellodendri with uncharacterized anti-inflammatory activity. We assessed the drug potential of niloticin and examined its ability to target myeloid differentiation protein 2 (MD-2) to ascertain the mechanism for its anti-inflammatory activity. Methods The Traditional Chinese Medicine Systems Pharmacology Database was used to evaluate niloticin. Bio-layer interferometry and molecular docking technologies were used to explore how niloticin targets MD-2, which mediates a series of toll-like receptor 4 (TLR4)-dependent inflammatory responses. The cytokines involved in the lipopolysaccharide (LPS)-TLR4/MD-2-NF-κB pathway were evaluated using ELISA, RT-qPCR, and western blotting. Results Niloticin could bind to MD-2 and had no evident effects on cell viability. Niloticin treatment significantly decreased the levels of NO, IL-6, TNF-α, and IL-1β induced by LPS ( p < 0.01). IL-1β, IL-6, iNOS, TNF-α, and COX-2 mRNA expression levels were decreased by niloticin (all p < 0.01). Compared with that in the control group, the increase in TLR4, p65, MyD88, p-p65, and iNOS expression levels induced by LPS were suppressed by niloticin (all p < 0.01). Conclusion Our results suggest that niloticin has therapeutic potential and binds to MD-2. Niloticin binding to MD-2 antagonized the effects of LPS binding to the TLR4/MD-2 complex, resulting in the inhibition of the LPS-TLR4/MD-2-NF-κB signaling pathway." @default.
• W4308181635 created "2022-11-08" @default.
• W4308181635 creator A5022256556 @default.
• W4308181635 creator A5045410942 @default.
• W4308181635 creator A5047761999 @default.
• W4308181635 creator A5057292712 @default.
• W4308181635 creator A5088376945 @default.
• W4308181635 date "2022-04-01" @default.
• W4308181635 modified "2023-10-14" @default.
• W4308181635 title "Niloticin binds to MD-2 to promote anti-inflammatory pathway activation in macrophage cells" @default.
• W4308181635 cites W1916932902 @default.
• W4308181635 cites W1965229126 @default.
• W4308181635 cites W1979096813 @default.
• W4308181635 cites W1995746214 @default.
• W4308181635 cites W2012992792 @default.
• W4308181635 cites W2014301459 @default.
• W4308181635 cites W2023534857 @default.
• W4308181635 cites W2026054859 @default.
• W4308181635 cites W2039817035 @default.
• W4308181635 cites W2059687396 @default.
• W4308181635 cites W2065118045 @default.
• W4308181635 cites W2072849913 @default.
• W4308181635 cites W2073875274 @default.
• W4308181635 cites W2105668062 @default.
• W4308181635 cites W2109812078 @default.
• W4308181635 cites W2124679671 @default.
• W4308181635 cites W2127934565 @default.
• W4308181635 cites W2131943372 @default.
• W4308181635 cites W2134967712 @default.
• W4308181635 cites W2135732933 @default.
• W4308181635 cites W2155984475 @default.
• W4308181635 cites W2161850897 @default.
• W4308181635 cites W2338850830 @default.
• W4308181635 cites W2393211462 @default.
• W4308181635 cites W2418350538 @default.
• W4308181635 cites W2594835699 @default.
• W4308181635 cites W2761468483 @default.
• W4308181635 cites W2792020729 @default.
• W4308181635 cites W2898085473 @default.
• W4308181635 cites W2900502372 @default.
• W4308181635 cites W2912116772 @default.
• W4308181635 cites W2919809468 @default.
• W4308181635 cites W2922074867 @default.
• W4308181635 cites W2927444945 @default.
• W4308181635 cites W2944557971 @default.
• W4308181635 cites W2945325276 @default.
• W4308181635 cites W2949766498 @default.
• W4308181635 cites W2988098732 @default.
• W4308181635 cites W3136979269 @default.
• W4308181635 cites W4234317413 @default.
• W4308181635 doi "https://doi.org/10.1177/03946320221133017" @default.
• W4308181635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36314579" @default.
• W4308181635 hasPublicationYear "2022" @default.
• W4308181635 type Work @default.
• W4308181635 citedByCount "0" @default.
• W4308181635 crossrefType "journal-article" @default.
• W4308181635 hasAuthorship W4308181635A5022256556 @default.
• W4308181635 hasAuthorship W4308181635A5045410942 @default.
• W4308181635 hasAuthorship W4308181635A5047761999 @default.
• W4308181635 hasAuthorship W4308181635A5057292712 @default.
• W4308181635 hasAuthorship W4308181635A5088376945 @default.
• W4308181635 hasBestOaLocation W43081816351 @default.
• W4308181635 hasConcept C104317684 @default.
• W4308181635 hasConcept C136449434 @default.
• W4308181635 hasConcept C153911025 @default.
• W4308181635 hasConcept C170493617 @default.
• W4308181635 hasConcept C17991360 @default.
• W4308181635 hasConcept C185592680 @default.
• W4308181635 hasConcept C203014093 @default.
• W4308181635 hasConcept C2776070231 @default.
• W4308181635 hasConcept C2776709828 @default.
• W4308181635 hasConcept C2777730290 @default.
• W4308181635 hasConcept C2778754761 @default.
• W4308181635 hasConcept C55493867 @default.
• W4308181635 hasConcept C62478195 @default.
• W4308181635 hasConcept C85265743 @default.
• W4308181635 hasConcept C86803240 @default.
• W4308181635 hasConcept C98274493 @default.
• W4308181635 hasConceptScore W4308181635C104317684 @default.
• W4308181635 hasConceptScore W4308181635C136449434 @default.
• W4308181635 hasConceptScore W4308181635C153911025 @default.
• W4308181635 hasConceptScore W4308181635C170493617 @default.
• W4308181635 hasConceptScore W4308181635C17991360 @default.
• W4308181635 hasConceptScore W4308181635C185592680 @default.
• W4308181635 hasConceptScore W4308181635C203014093 @default.
• W4308181635 hasConceptScore W4308181635C2776070231 @default.
• W4308181635 hasConceptScore W4308181635C2776709828 @default.
• W4308181635 hasConceptScore W4308181635C2777730290 @default.
• W4308181635 hasConceptScore W4308181635C2778754761 @default.
• W4308181635 hasConceptScore W4308181635C55493867 @default.
• W4308181635 hasConceptScore W4308181635C62478195 @default.
• W4308181635 hasConceptScore W4308181635C85265743 @default.
• W4308181635 hasConceptScore W4308181635C86803240 @default.
• W4308181635 hasConceptScore W4308181635C98274493 @default.
• W4308181635 hasFunder F4320321001 @default.
• W4308181635 hasLocation W43081816351 @default.
• W4308181635 hasLocation W43081816352 @default.
• W4308181635 hasLocation W43081816353 @default.

• next